Search - tctmd.com

Displaying 401 - 420 of 699

Sort: Relevancy | Date

Presentation TCT 2016

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder

October 30, 2016

Presentation TCT 2016

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Presenter: Gary M. Ansel, Michael R. Jaff

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri

October 30, 2016

Presentation TCT 2016

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

Presenter: Gary M. Ansel, Michael R. Jaff, Sahil A. Parikh

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams

October 30, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Aortoiliac Intervention

Presenter: D. Christopher Metzger, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert

October 30, 2016

Presentation TCT 2016

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Felix Mahfoud

October 30, 2016

Presentation TCT 2016

Management of Complications From Aortoiliac Intervention

Presenter: D. Christopher Metzger, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Hypertension Treatment Targets Beyond the Kidneys

Presenter: Felix Mahfoud, Michael A. Weber, Atul Pathak

October 30, 2016

Presentation TCT 2016

Optimal Stent Selection for Aortoiliac Intervention: Understanding the Differences

Presenter: D. Christopher Metzger, Constantino S. Pena, Ehrin J. Armstrong

October 30, 2016

Presentation TCT 2016

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner

October 30, 2016

Presentation TCT 2016

Technical Components of Iliac Artery Occlusion Endovascular Treatment: The Tips and Tricks

Presenter: D. Christopher Metzger, Constantino S. Pena, David P. Slovut

October 30, 2016

Presentation TCT 2016

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Presenter: Felix Mahfoud, Michael A. Weber, Ehtisham Mahmud

October 30, 2016

Presentation TCT 2016

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Presenter: Felix Mahfoud, Michael A. Weber

October 30, 2016

Presentation TCT 2016

Introduction to the TCT 2016 Peripheral Vascular Intervention Sessions

Presenter: D. Christopher Metzger, Constantino S. Pena, Michael R. Jaff

October 30, 2016

Presentation TCT 2016

TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity Nationwide Study of Acute Kidney Injury Following Coronary Angiography and Intervention

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Advertisement

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

LIVE-IN-A-BOX CASE DEMONSTRATION: Aortoiliac Intervention

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Management of Complications From Aortoiliac Intervention

Hypertension Treatment Targets Beyond the Kidneys

Optimal Stent Selection for Aortoiliac Intervention: Understanding the Differences

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Technical Components of Iliac Artery Occlusion Endovascular Treatment: The Tips and Tricks

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Introduction to the TCT 2016 Peripheral Vascular Intervention Sessions

TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity Nationwide Study of Acute Kidney Injury Following Coronary Angiography and Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content